nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—coronary artery disease—type 2 diabetes mellitus	0.183	0.626	CtDrD
Captopril—Enalapril—Nateglinide—type 2 diabetes mellitus	0.111	0.622	CrCrCtD
Captopril—hypertension—type 2 diabetes mellitus	0.109	0.374	CtDrD
Captopril—MMP9—type 2 diabetes mellitus	0.0836	0.511	CbGaD
Captopril—Enalapril—Ramipril—type 2 diabetes mellitus	0.0676	0.378	CrCrCtD
Captopril—ACE—type 2 diabetes mellitus	0.0568	0.347	CbGaD
Captopril—ACE—Ramipril—type 2 diabetes mellitus	0.0301	0.142	CbGbCtD
Captopril—ALB—type 2 diabetes mellitus	0.0233	0.142	CbGaD
Captopril—ACE—Losartan—type 2 diabetes mellitus	0.0177	0.0836	CbGbCtD
Captopril—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.0152	0.0716	CbGbCtD
Captopril—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.0135	0.0638	CbGbCtD
Captopril—SLC15A1—Ramipril—type 2 diabetes mellitus	0.0121	0.0569	CbGbCtD
Captopril—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.0115	0.0542	CbGbCtD
Captopril—ALB—Gliclazide—type 2 diabetes mellitus	0.00839	0.0395	CbGbCtD
Captopril—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.00837	0.0394	CbGbCtD
Captopril—ALB—Repaglinide—type 2 diabetes mellitus	0.00788	0.0371	CbGbCtD
Captopril—SLC15A1—Glyburide—type 2 diabetes mellitus	0.00778	0.0366	CbGbCtD
Captopril—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.00746	0.0352	CbGbCtD
Captopril—ALB—Rosiglitazone—type 2 diabetes mellitus	0.00658	0.031	CbGbCtD
Captopril—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.00634	0.0299	CbGbCtD
Captopril—ALB—Valsartan—type 2 diabetes mellitus	0.00581	0.0274	CbGbCtD
Captopril—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00579	0.0273	CbGbCtD
Captopril—ALB—Nateglinide—type 2 diabetes mellitus	0.0054	0.0255	CbGbCtD
Captopril—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00516	0.0243	CbGbCtD
Captopril—SLC22A6—Glyburide—type 2 diabetes mellitus	0.00429	0.0202	CbGbCtD
Captopril—SLC22A6—Losartan—type 2 diabetes mellitus	0.00392	0.0185	CbGbCtD
Captopril—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00373	0.0176	CbGbCtD
Captopril—ALB—Glyburide—type 2 diabetes mellitus	0.00365	0.0172	CbGbCtD
Captopril—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00351	0.0166	CbGbCtD
Captopril—ALB—Losartan—type 2 diabetes mellitus	0.00334	0.0157	CbGbCtD
Captopril—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00324	0.0153	CbGbCtD
Captopril—REN—arteriole—type 2 diabetes mellitus	0.00296	0.0744	CbGeAlD
Captopril—MMP9—middle cerebral artery—type 2 diabetes mellitus	0.00268	0.0675	CbGeAlD
Captopril—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00266	0.0125	CbGbCtD
Captopril—REN—forelimb zeugopod—type 2 diabetes mellitus	0.00259	0.0651	CbGeAlD
Captopril—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00256	0.0121	CbGbCtD
Captopril—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00255	0.012	CbGbCtD
Captopril—MMP2—tunica intima—type 2 diabetes mellitus	0.00193	0.0485	CbGeAlD
Captopril—ABCB1—Glyburide—type 2 diabetes mellitus	0.00191	0.009	CbGbCtD
Captopril—REN—sympathetic nervous system—type 2 diabetes mellitus	0.00188	0.0474	CbGeAlD
Captopril—ABCB1—Losartan—type 2 diabetes mellitus	0.00175	0.00823	CbGbCtD
Captopril—MMP9—tunica intima—type 2 diabetes mellitus	0.00168	0.0422	CbGeAlD
Captopril—REN—autonomic nervous system—type 2 diabetes mellitus	0.00127	0.0319	CbGeAlD
Captopril—ACE—arteriole—type 2 diabetes mellitus	0.00126	0.0317	CbGeAlD
Captopril—ACE—forelimb zeugopod—type 2 diabetes mellitus	0.0011	0.0278	CbGeAlD
Captopril—MMP2—hindlimb—type 2 diabetes mellitus	0.00108	0.0271	CbGeAlD
Captopril—MMP9—hindlimb—type 2 diabetes mellitus	0.000937	0.0236	CbGeAlD
Captopril—F2—leg—type 2 diabetes mellitus	0.000915	0.023	CbGeAlD
Captopril—REN—peripheral nervous system—type 2 diabetes mellitus	0.000914	0.023	CbGeAlD
Captopril—ACE—tunica intima—type 2 diabetes mellitus	0.000894	0.0225	CbGeAlD
Captopril—F2—hindlimb—type 2 diabetes mellitus	0.000817	0.0206	CbGeAlD
Captopril—ACE—sympathetic nervous system—type 2 diabetes mellitus	0.000803	0.0202	CbGeAlD
Captopril—REN—artery—type 2 diabetes mellitus	0.000718	0.0181	CbGeAlD
Captopril—REN—nerve—type 2 diabetes mellitus	0.000713	0.0179	CbGeAlD
Captopril—MMP2—artery—type 2 diabetes mellitus	0.00066	0.0166	CbGeAlD
Captopril—MMP9—artery—type 2 diabetes mellitus	0.000574	0.0144	CbGeAlD
Captopril—MMP2—endothelium—type 2 diabetes mellitus	0.000558	0.014	CbGeAlD
Captopril—ACE—autonomic nervous system—type 2 diabetes mellitus	0.00054	0.0136	CbGeAlD
Captopril—F2—artery—type 2 diabetes mellitus	0.000501	0.0126	CbGeAlD
Captopril—ACE—hindlimb—type 2 diabetes mellitus	0.000499	0.0126	CbGeAlD
Captopril—MMP9—endothelium—type 2 diabetes mellitus	0.000485	0.0122	CbGeAlD
Captopril—LTA4H—islet of Langerhans—type 2 diabetes mellitus	0.000447	0.0112	CbGeAlD
Captopril—F2—endothelium—type 2 diabetes mellitus	0.000423	0.0106	CbGeAlD
Captopril—ACE—peripheral nervous system—type 2 diabetes mellitus	0.000389	0.00979	CbGeAlD
Captopril—LTA4H—retina—type 2 diabetes mellitus	0.000382	0.00961	CbGeAlD
Captopril—LTA4H—nephron tubule—type 2 diabetes mellitus	0.00036	0.00905	CbGeAlD
Captopril—LTA4H—cardiovascular system—type 2 diabetes mellitus	0.000323	0.00813	CbGeAlD
Captopril—MMP2—islet of Langerhans—type 2 diabetes mellitus	0.000317	0.00798	CbGeAlD
Captopril—LTA4H—kidney—type 2 diabetes mellitus	0.000316	0.00796	CbGeAlD
Captopril—LTA4H—pancreas—type 2 diabetes mellitus	0.000314	0.0079	CbGeAlD
Captopril—LTA4H—cortex of kidney—type 2 diabetes mellitus	0.000308	0.00775	CbGeAlD
Captopril—ACE—artery—type 2 diabetes mellitus	0.000306	0.0077	CbGeAlD
Captopril—ACE—nerve—type 2 diabetes mellitus	0.000304	0.00764	CbGeAlD
Captopril—Enalapril—ACE—type 2 diabetes mellitus	0.0003	0.68	CrCbGaD
Captopril—LTA4H—adipose tissue—type 2 diabetes mellitus	0.000285	0.00717	CbGeAlD
Captopril—REN—nephron tubule—type 2 diabetes mellitus	0.000278	0.00699	CbGeAlD
Captopril—MMP2—retina—type 2 diabetes mellitus	0.000271	0.00682	CbGeAlD
Captopril—ACE—endothelium—type 2 diabetes mellitus	0.000259	0.0065	CbGeAlD
Captopril—REN—cardiovascular system—type 2 diabetes mellitus	0.00025	0.00628	CbGeAlD
Captopril—REN—kidney—type 2 diabetes mellitus	0.000244	0.00614	CbGeAlD
Captopril—MMP2—Glyburide—Glimepiride—type 2 diabetes mellitus	0.000241	0.17	CbGdCrCtD
Captopril—MMP2—Glyburide—Tolazamide—type 2 diabetes mellitus	0.000241	0.17	CbGdCrCtD
Captopril—REN—cortex of kidney—type 2 diabetes mellitus	0.000238	0.00598	CbGeAlD
Captopril—MMP2—cardiovascular system—type 2 diabetes mellitus	0.000229	0.00577	CbGeAlD
Captopril—MMP2—Glyburide—Gliclazide—type 2 diabetes mellitus	0.000228	0.161	CbGdCrCtD
Captopril—MMP2—Glyburide—Glipizide—type 2 diabetes mellitus	0.000228	0.161	CbGdCrCtD
Captopril—MMP2—kidney—type 2 diabetes mellitus	0.000224	0.00565	CbGeAlD
Captopril—MMP2—pancreas—type 2 diabetes mellitus	0.000223	0.00561	CbGeAlD
Captopril—MMP2—cortex of kidney—type 2 diabetes mellitus	0.000219	0.0055	CbGeAlD
Captopril—MMP2—Glyburide—Chlorpropamide—type 2 diabetes mellitus	0.000209	0.148	CbGdCrCtD
Captopril—MMP2—adipose tissue—type 2 diabetes mellitus	0.000202	0.00509	CbGeAlD
Captopril—LTA4H—liver—type 2 diabetes mellitus	0.0002	0.00503	CbGeAlD
Captopril—MMP9—cardiovascular system—type 2 diabetes mellitus	0.0002	0.00502	CbGeAlD
Captopril—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.000198	0.00499	CbGeAlD
Captopril—MMP9—kidney—type 2 diabetes mellitus	0.000195	0.00491	CbGeAlD
Captopril—MMP9—pancreas—type 2 diabetes mellitus	0.000194	0.00488	CbGeAlD
Captopril—MMP9—adipose tissue—type 2 diabetes mellitus	0.000176	0.00443	CbGeAlD
Captopril—F2—cardiovascular system—type 2 diabetes mellitus	0.000174	0.00438	CbGeAlD
Captopril—F2—kidney—type 2 diabetes mellitus	0.00017	0.00428	CbGeAlD
Captopril—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.00017	0.00427	CbGeAlD
Captopril—MMP2—Enalapril—Nateglinide—type 2 diabetes mellitus	0.000166	0.118	CbGdCrCtD
Captopril—SLC15A1—nephron tubule—type 2 diabetes mellitus	0.000165	0.00415	CbGeAlD
Captopril—REN—liver—type 2 diabetes mellitus	0.000154	0.00388	CbGeAlD
Captopril—SLC15A1—kidney—type 2 diabetes mellitus	0.000145	0.00365	CbGeAlD
Captopril—MMP2—liver—type 2 diabetes mellitus	0.000142	0.00357	CbGeAlD
Captopril—Enalapril—CYP3A4—type 2 diabetes mellitus	0.000141	0.32	CrCbGaD
Captopril—MMP9—liver—type 2 diabetes mellitus	0.000123	0.0031	CbGeAlD
Captopril—ACE—nephron tubule—type 2 diabetes mellitus	0.000118	0.00298	CbGeAlD
Captopril—F2—liver—type 2 diabetes mellitus	0.000108	0.00271	CbGeAlD
Captopril—ACE—cardiovascular system—type 2 diabetes mellitus	0.000106	0.00267	CbGeAlD
Captopril—ACE—kidney—type 2 diabetes mellitus	0.000104	0.00262	CbGeAlD
Captopril—ACE—cortex of kidney—type 2 diabetes mellitus	0.000101	0.00255	CbGeAlD
Captopril—MMP2—Enalapril—Ramipril—type 2 diabetes mellitus	0.000101	0.0716	CbGdCrCtD
Captopril—ACE—adipose tissue—type 2 diabetes mellitus	9.38e-05	0.00236	CbGeAlD
Captopril—SLC15A1—liver—type 2 diabetes mellitus	9.17e-05	0.00231	CbGeAlD
Captopril—ALB—liver—type 2 diabetes mellitus	6.87e-05	0.00173	CbGeAlD
Captopril—ACE—liver—type 2 diabetes mellitus	6.58e-05	0.00165	CbGeAlD
Captopril—ABCB1—islet of Langerhans—type 2 diabetes mellitus	5.18e-05	0.0013	CbGeAlD
Captopril—CYP2D6—kidney—type 2 diabetes mellitus	5.09e-05	0.00128	CbGeAlD
Captopril—ABCB1—retina—type 2 diabetes mellitus	4.43e-05	0.00111	CbGeAlD
Captopril—ABCB1—nephron tubule—type 2 diabetes mellitus	4.17e-05	0.00105	CbGeAlD
Captopril—ABCB1—cardiovascular system—type 2 diabetes mellitus	3.74e-05	0.000942	CbGeAlD
Captopril—ABCB1—kidney—type 2 diabetes mellitus	3.66e-05	0.000921	CbGeAlD
Captopril—ABCB1—pancreas—type 2 diabetes mellitus	3.64e-05	0.000915	CbGeAlD
Captopril—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	3.62e-05	0.000575	CcSEcCtD
Captopril—Hepatitis—Ramipril—type 2 diabetes mellitus	3.62e-05	0.000574	CcSEcCtD
Captopril—Anaemia—Irbesartan—type 2 diabetes mellitus	3.61e-05	0.000572	CcSEcCtD
Captopril—Tension—Losartan—type 2 diabetes mellitus	3.6e-05	0.000572	CcSEcCtD
Captopril—Dizziness—Glimepiride—type 2 diabetes mellitus	3.6e-05	0.000572	CcSEcCtD
Captopril—Dysgeusia—Losartan—type 2 diabetes mellitus	3.6e-05	0.000571	CcSEcCtD
Captopril—Dyspnoea—Gliclazide—type 2 diabetes mellitus	3.6e-05	0.000571	CcSEcCtD
Captopril—Dizziness—Sitagliptin—type 2 diabetes mellitus	3.59e-05	0.00057	CcSEcCtD
Captopril—Somnolence—Gliclazide—type 2 diabetes mellitus	3.59e-05	0.000569	CcSEcCtD
Captopril—Nervousness—Losartan—type 2 diabetes mellitus	3.57e-05	0.000566	CcSEcCtD
Captopril—ABCB1—cortex of kidney—type 2 diabetes mellitus	3.57e-05	0.000897	CbGeAlD
Captopril—Angioedema—Irbesartan—type 2 diabetes mellitus	3.57e-05	0.000566	CcSEcCtD
Captopril—Abdominal pain—Glyburide—type 2 diabetes mellitus	3.55e-05	0.000564	CcSEcCtD
Captopril—Dyspepsia—Gliclazide—type 2 diabetes mellitus	3.55e-05	0.000563	CcSEcCtD
Captopril—Anorexia—Valsartan—type 2 diabetes mellitus	3.53e-05	0.000561	CcSEcCtD
Captopril—Asthenia—Bromocriptine—type 2 diabetes mellitus	3.53e-05	0.000559	CcSEcCtD
Captopril—Chest pain—Metformin—type 2 diabetes mellitus	3.52e-05	0.000559	CcSEcCtD
Captopril—Myalgia—Metformin—type 2 diabetes mellitus	3.52e-05	0.000559	CcSEcCtD
Captopril—Malaise—Irbesartan—type 2 diabetes mellitus	3.52e-05	0.000558	CcSEcCtD
Captopril—Headache—Pioglitazone—type 2 diabetes mellitus	3.5e-05	0.000556	CcSEcCtD
Captopril—Syncope—Irbesartan—type 2 diabetes mellitus	3.5e-05	0.000555	CcSEcCtD
Captopril—Discomfort—Metformin—type 2 diabetes mellitus	3.48e-05	0.000552	CcSEcCtD
Captopril—Fatigue—Gliclazide—type 2 diabetes mellitus	3.48e-05	0.000552	CcSEcCtD
Captopril—Nausea—Glipizide—type 2 diabetes mellitus	3.47e-05	0.00055	CcSEcCtD
Captopril—Vomiting—Glimepiride—type 2 diabetes mellitus	3.46e-05	0.00055	CcSEcCtD
Captopril—Hypotension—Valsartan—type 2 diabetes mellitus	3.46e-05	0.00055	CcSEcCtD
Captopril—Vision blurred—Losartan—type 2 diabetes mellitus	3.46e-05	0.000549	CcSEcCtD
Captopril—Vomiting—Sitagliptin—type 2 diabetes mellitus	3.45e-05	0.000548	CcSEcCtD
Captopril—Constipation—Gliclazide—type 2 diabetes mellitus	3.45e-05	0.000547	CcSEcCtD
Captopril—Rash—Glimepiride—type 2 diabetes mellitus	3.44e-05	0.000545	CcSEcCtD
Captopril—Dermatitis—Glimepiride—type 2 diabetes mellitus	3.43e-05	0.000545	CcSEcCtD
Captopril—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	3.43e-05	0.000544	CcSEcCtD
Captopril—Rash—Sitagliptin—type 2 diabetes mellitus	3.42e-05	0.000543	CcSEcCtD
Captopril—Dermatitis—Sitagliptin—type 2 diabetes mellitus	3.42e-05	0.000543	CcSEcCtD
Captopril—Erythema multiforme—Ramipril—type 2 diabetes mellitus	3.42e-05	0.000543	CcSEcCtD
Captopril—Headache—Glimepiride—type 2 diabetes mellitus	3.41e-05	0.000542	CcSEcCtD
Captopril—Ill-defined disorder—Losartan—type 2 diabetes mellitus	3.41e-05	0.000541	CcSEcCtD
Captopril—Cough—Irbesartan—type 2 diabetes mellitus	3.41e-05	0.00054	CcSEcCtD
Captopril—Headache—Sitagliptin—type 2 diabetes mellitus	3.4e-05	0.00054	CcSEcCtD
Captopril—Anaemia—Losartan—type 2 diabetes mellitus	3.4e-05	0.000539	CcSEcCtD
Captopril—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	3.38e-05	0.000536	CcSEcCtD
Captopril—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	3.36e-05	0.000534	CcSEcCtD
Captopril—Flushing—Ramipril—type 2 diabetes mellitus	3.36e-05	0.000533	CcSEcCtD
Captopril—Angioedema—Losartan—type 2 diabetes mellitus	3.36e-05	0.000533	CcSEcCtD
Captopril—Insomnia—Valsartan—type 2 diabetes mellitus	3.35e-05	0.000532	CcSEcCtD
Captopril—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	3.34e-05	0.000529	CcSEcCtD
Captopril—Paraesthesia—Valsartan—type 2 diabetes mellitus	3.33e-05	0.000528	CcSEcCtD
Captopril—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	3.33e-05	0.000527	CcSEcCtD
Captopril—Myalgia—Irbesartan—type 2 diabetes mellitus	3.32e-05	0.000527	CcSEcCtD
Captopril—Arthralgia—Irbesartan—type 2 diabetes mellitus	3.32e-05	0.000527	CcSEcCtD
Captopril—Chest pain—Irbesartan—type 2 diabetes mellitus	3.32e-05	0.000527	CcSEcCtD
Captopril—Shock—Metformin—type 2 diabetes mellitus	3.32e-05	0.000527	CcSEcCtD
Captopril—Insomnia—Orlistat—type 2 diabetes mellitus	3.31e-05	0.000526	CcSEcCtD
Captopril—Malaise—Losartan—type 2 diabetes mellitus	3.31e-05	0.000526	CcSEcCtD
Captopril—Thrombocytopenia—Metformin—type 2 diabetes mellitus	3.31e-05	0.000524	CcSEcCtD
Captopril—Dyspnoea—Valsartan—type 2 diabetes mellitus	3.31e-05	0.000524	CcSEcCtD
Captopril—ABCB1—adipose tissue—type 2 diabetes mellitus	3.3e-05	0.00083	CbGeAlD
Captopril—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	3.3e-05	0.000523	CcSEcCtD
Captopril—Somnolence—Valsartan—type 2 diabetes mellitus	3.3e-05	0.000523	CcSEcCtD
Captopril—Syncope—Losartan—type 2 diabetes mellitus	3.29e-05	0.000523	CcSEcCtD
Captopril—Paraesthesia—Orlistat—type 2 diabetes mellitus	3.29e-05	0.000522	CcSEcCtD
Captopril—Discomfort—Irbesartan—type 2 diabetes mellitus	3.28e-05	0.000521	CcSEcCtD
Captopril—Dyspepsia—Valsartan—type 2 diabetes mellitus	3.26e-05	0.000518	CcSEcCtD
Captopril—Dizziness—Bromocriptine—type 2 diabetes mellitus	3.25e-05	0.000516	CcSEcCtD
Captopril—Dry mouth—Irbesartan—type 2 diabetes mellitus	3.25e-05	0.000516	CcSEcCtD
Captopril—Palpitations—Losartan—type 2 diabetes mellitus	3.25e-05	0.000515	CcSEcCtD
Captopril—Nausea—Glimepiride—type 2 diabetes mellitus	3.24e-05	0.000513	CcSEcCtD
Captopril—Loss of consciousness—Losartan—type 2 diabetes mellitus	3.23e-05	0.000512	CcSEcCtD
Captopril—Nausea—Sitagliptin—type 2 diabetes mellitus	3.23e-05	0.000512	CcSEcCtD
Captopril—Dyspepsia—Orlistat—type 2 diabetes mellitus	3.22e-05	0.000512	CcSEcCtD
Captopril—Asthenia—Glyburide—type 2 diabetes mellitus	3.22e-05	0.000511	CcSEcCtD
Captopril—Decreased appetite—Valsartan—type 2 diabetes mellitus	3.22e-05	0.000511	CcSEcCtD
Captopril—CYP2D6—liver—type 2 diabetes mellitus	3.22e-05	0.00081	CbGeAlD
Captopril—Anorexia—Metformin—type 2 diabetes mellitus	3.22e-05	0.00051	CcSEcCtD
Captopril—Cough—Losartan—type 2 diabetes mellitus	3.21e-05	0.000509	CcSEcCtD
Captopril—Alopecia—Ramipril—type 2 diabetes mellitus	3.2e-05	0.000507	CcSEcCtD
Captopril—Fatigue—Valsartan—type 2 diabetes mellitus	3.2e-05	0.000507	CcSEcCtD
Captopril—Abdominal pain—Gliclazide—type 2 diabetes mellitus	3.19e-05	0.000506	CcSEcCtD
Captopril—Body temperature increased—Gliclazide—type 2 diabetes mellitus	3.19e-05	0.000506	CcSEcCtD
Captopril—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	3.19e-05	0.000505	CcSEcCtD
Captopril—Decreased appetite—Orlistat—type 2 diabetes mellitus	3.18e-05	0.000505	CcSEcCtD
Captopril—Pruritus—Glyburide—type 2 diabetes mellitus	3.18e-05	0.000504	CcSEcCtD
Captopril—Constipation—Valsartan—type 2 diabetes mellitus	3.17e-05	0.000503	CcSEcCtD
Captopril—Fatigue—Orlistat—type 2 diabetes mellitus	3.16e-05	0.000501	CcSEcCtD
Captopril—Hypotension—Metformin—type 2 diabetes mellitus	3.15e-05	0.0005	CcSEcCtD
Captopril—Shock—Irbesartan—type 2 diabetes mellitus	3.13e-05	0.000497	CcSEcCtD
Captopril—Chest pain—Losartan—type 2 diabetes mellitus	3.13e-05	0.000496	CcSEcCtD
Captopril—Arthralgia—Losartan—type 2 diabetes mellitus	3.13e-05	0.000496	CcSEcCtD
Captopril—Myalgia—Losartan—type 2 diabetes mellitus	3.13e-05	0.000496	CcSEcCtD
Captopril—Vomiting—Bromocriptine—type 2 diabetes mellitus	3.13e-05	0.000496	CcSEcCtD
Captopril—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	3.12e-05	0.000495	CcSEcCtD
Captopril—Tachycardia—Irbesartan—type 2 diabetes mellitus	3.11e-05	0.000493	CcSEcCtD
Captopril—Rash—Bromocriptine—type 2 diabetes mellitus	3.1e-05	0.000492	CcSEcCtD
Captopril—Dermatitis—Bromocriptine—type 2 diabetes mellitus	3.1e-05	0.000491	CcSEcCtD
Captopril—Tension—Ramipril—type 2 diabetes mellitus	3.09e-05	0.00049	CcSEcCtD
Captopril—Discomfort—Losartan—type 2 diabetes mellitus	3.09e-05	0.00049	CcSEcCtD
Captopril—Dysgeusia—Ramipril—type 2 diabetes mellitus	3.08e-05	0.000489	CcSEcCtD
Captopril—Headache—Bromocriptine—type 2 diabetes mellitus	3.08e-05	0.000489	CcSEcCtD
Captopril—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	3.08e-05	0.000488	CcSEcCtD
Captopril—Diarrhoea—Glyburide—type 2 diabetes mellitus	3.07e-05	0.000488	CcSEcCtD
Captopril—Nervousness—Ramipril—type 2 diabetes mellitus	3.06e-05	0.000485	CcSEcCtD
Captopril—Dry mouth—Losartan—type 2 diabetes mellitus	3.06e-05	0.000485	CcSEcCtD
Captopril—Anorexia—Irbesartan—type 2 diabetes mellitus	3.04e-05	0.000482	CcSEcCtD
Captopril—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	3.03e-05	0.000481	CcSEcCtD
Captopril—Paraesthesia—Metformin—type 2 diabetes mellitus	3.03e-05	0.000481	CcSEcCtD
Captopril—Confusional state—Losartan—type 2 diabetes mellitus	3.02e-05	0.00048	CcSEcCtD
Captopril—Feeling abnormal—Orlistat—type 2 diabetes mellitus	3.02e-05	0.000479	CcSEcCtD
Captopril—Dyspnoea—Metformin—type 2 diabetes mellitus	3.01e-05	0.000477	CcSEcCtD
Captopril—Somnolence—Metformin—type 2 diabetes mellitus	3e-05	0.000476	CcSEcCtD
Captopril—Anaphylactic shock—Losartan—type 2 diabetes mellitus	3e-05	0.000476	CcSEcCtD
Captopril—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	3e-05	0.000475	CcSEcCtD
Captopril—Hypotension—Irbesartan—type 2 diabetes mellitus	2.98e-05	0.000472	CcSEcCtD
Captopril—Dyspepsia—Metformin—type 2 diabetes mellitus	2.97e-05	0.000471	CcSEcCtD
Captopril—Shock—Losartan—type 2 diabetes mellitus	2.95e-05	0.000468	CcSEcCtD
Captopril—Thrombocytopenia—Losartan—type 2 diabetes mellitus	2.94e-05	0.000466	CcSEcCtD
Captopril—Decreased appetite—Metformin—type 2 diabetes mellitus	2.93e-05	0.000466	CcSEcCtD
Captopril—Abdominal pain—Valsartan—type 2 diabetes mellitus	2.93e-05	0.000465	CcSEcCtD
Captopril—Tachycardia—Losartan—type 2 diabetes mellitus	2.93e-05	0.000464	CcSEcCtD
Captopril—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	2.92e-05	0.000464	CcSEcCtD
Captopril—Nausea—Bromocriptine—type 2 diabetes mellitus	2.92e-05	0.000463	CcSEcCtD
Captopril—Fatigue—Metformin—type 2 diabetes mellitus	2.91e-05	0.000462	CcSEcCtD
Captopril—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	2.9e-05	0.00046	CcSEcCtD
Captopril—Body temperature increased—Orlistat—type 2 diabetes mellitus	2.9e-05	0.000459	CcSEcCtD
Captopril—Abdominal pain—Orlistat—type 2 diabetes mellitus	2.9e-05	0.000459	CcSEcCtD
Captopril—Asthenia—Gliclazide—type 2 diabetes mellitus	2.89e-05	0.000459	CcSEcCtD
Captopril—Constipation—Metformin—type 2 diabetes mellitus	2.89e-05	0.000458	CcSEcCtD
Captopril—Angioedema—Ramipril—type 2 diabetes mellitus	2.88e-05	0.000457	CcSEcCtD
Captopril—Paraesthesia—Irbesartan—type 2 diabetes mellitus	2.86e-05	0.000454	CcSEcCtD
Captopril—Anorexia—Losartan—type 2 diabetes mellitus	2.86e-05	0.000453	CcSEcCtD
Captopril—Vomiting—Glyburide—type 2 diabetes mellitus	2.86e-05	0.000453	CcSEcCtD
Captopril—Pruritus—Gliclazide—type 2 diabetes mellitus	2.85e-05	0.000453	CcSEcCtD
Captopril—Malaise—Ramipril—type 2 diabetes mellitus	2.84e-05	0.000451	CcSEcCtD
Captopril—Dyspnoea—Irbesartan—type 2 diabetes mellitus	2.84e-05	0.000451	CcSEcCtD
Captopril—Rash—Glyburide—type 2 diabetes mellitus	2.83e-05	0.000449	CcSEcCtD
Captopril—Somnolence—Irbesartan—type 2 diabetes mellitus	2.83e-05	0.000449	CcSEcCtD
Captopril—Dermatitis—Glyburide—type 2 diabetes mellitus	2.83e-05	0.000449	CcSEcCtD
Captopril—Syncope—Ramipril—type 2 diabetes mellitus	2.82e-05	0.000448	CcSEcCtD
Captopril—Headache—Glyburide—type 2 diabetes mellitus	2.82e-05	0.000447	CcSEcCtD
Captopril—Dyspepsia—Irbesartan—type 2 diabetes mellitus	2.8e-05	0.000445	CcSEcCtD
Captopril—Hypotension—Losartan—type 2 diabetes mellitus	2.8e-05	0.000444	CcSEcCtD
Captopril—Palpitations—Ramipril—type 2 diabetes mellitus	2.78e-05	0.000442	CcSEcCtD
Captopril—Feeling abnormal—Metformin—type 2 diabetes mellitus	2.78e-05	0.000441	CcSEcCtD
Captopril—Decreased appetite—Irbesartan—type 2 diabetes mellitus	2.77e-05	0.000439	CcSEcCtD
Captopril—Loss of consciousness—Ramipril—type 2 diabetes mellitus	2.77e-05	0.000439	CcSEcCtD
Captopril—Diarrhoea—Gliclazide—type 2 diabetes mellitus	2.76e-05	0.000438	CcSEcCtD
Captopril—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	2.76e-05	0.000438	CcSEcCtD
Captopril—Cough—Ramipril—type 2 diabetes mellitus	2.75e-05	0.000436	CcSEcCtD
Captopril—Fatigue—Irbesartan—type 2 diabetes mellitus	2.75e-05	0.000436	CcSEcCtD
Captopril—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	2.73e-05	0.000433	CcSEcCtD
Captopril—Constipation—Irbesartan—type 2 diabetes mellitus	2.72e-05	0.000432	CcSEcCtD
Captopril—Insomnia—Losartan—type 2 diabetes mellitus	2.71e-05	0.00043	CcSEcCtD
Captopril—Paraesthesia—Losartan—type 2 diabetes mellitus	2.69e-05	0.000427	CcSEcCtD
Captopril—Arthralgia—Ramipril—type 2 diabetes mellitus	2.68e-05	0.000425	CcSEcCtD
Captopril—Chest pain—Ramipril—type 2 diabetes mellitus	2.68e-05	0.000425	CcSEcCtD
Captopril—Myalgia—Ramipril—type 2 diabetes mellitus	2.68e-05	0.000425	CcSEcCtD
Captopril—Dyspnoea—Losartan—type 2 diabetes mellitus	2.67e-05	0.000424	CcSEcCtD
Captopril—Nausea—Glyburide—type 2 diabetes mellitus	2.67e-05	0.000423	CcSEcCtD
Captopril—Abdominal pain—Metformin—type 2 diabetes mellitus	2.67e-05	0.000423	CcSEcCtD
Captopril—Dizziness—Gliclazide—type 2 diabetes mellitus	2.67e-05	0.000423	CcSEcCtD
Captopril—Somnolence—Losartan—type 2 diabetes mellitus	2.67e-05	0.000423	CcSEcCtD
Captopril—Asthenia—Valsartan—type 2 diabetes mellitus	2.66e-05	0.000422	CcSEcCtD
Captopril—Discomfort—Ramipril—type 2 diabetes mellitus	2.65e-05	0.00042	CcSEcCtD
Captopril—Dyspepsia—Losartan—type 2 diabetes mellitus	2.64e-05	0.000419	CcSEcCtD
Captopril—Asthenia—Orlistat—type 2 diabetes mellitus	2.63e-05	0.000417	CcSEcCtD
Captopril—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	2.63e-05	0.000416	CcSEcCtD
Captopril—Pruritus—Valsartan—type 2 diabetes mellitus	2.62e-05	0.000416	CcSEcCtD
Captopril—Dry mouth—Ramipril—type 2 diabetes mellitus	2.62e-05	0.000416	CcSEcCtD
Captopril—Decreased appetite—Losartan—type 2 diabetes mellitus	2.61e-05	0.000413	CcSEcCtD
Captopril—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	2.61e-05	0.000413	CcSEcCtD
Captopril—Confusional state—Ramipril—type 2 diabetes mellitus	2.59e-05	0.000411	CcSEcCtD
Captopril—Pruritus—Orlistat—type 2 diabetes mellitus	2.59e-05	0.000411	CcSEcCtD
Captopril—Fatigue—Losartan—type 2 diabetes mellitus	2.58e-05	0.00041	CcSEcCtD
Captopril—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	2.57e-05	0.000408	CcSEcCtD
Captopril—Vomiting—Gliclazide—type 2 diabetes mellitus	2.57e-05	0.000407	CcSEcCtD
Captopril—Constipation—Losartan—type 2 diabetes mellitus	2.56e-05	0.000407	CcSEcCtD
Captopril—Rash—Gliclazide—type 2 diabetes mellitus	2.54e-05	0.000404	CcSEcCtD
Captopril—Dermatitis—Gliclazide—type 2 diabetes mellitus	2.54e-05	0.000403	CcSEcCtD
Captopril—Diarrhoea—Valsartan—type 2 diabetes mellitus	2.54e-05	0.000402	CcSEcCtD
Captopril—Shock—Ramipril—type 2 diabetes mellitus	2.53e-05	0.000401	CcSEcCtD
Captopril—Headache—Gliclazide—type 2 diabetes mellitus	2.53e-05	0.000401	CcSEcCtD
Captopril—Body temperature increased—Irbesartan—type 2 diabetes mellitus	2.52e-05	0.0004	CcSEcCtD
Captopril—Abdominal pain—Irbesartan—type 2 diabetes mellitus	2.52e-05	0.0004	CcSEcCtD
Captopril—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	2.52e-05	0.000399	CcSEcCtD
Captopril—Tachycardia—Ramipril—type 2 diabetes mellitus	2.51e-05	0.000398	CcSEcCtD
Captopril—Diarrhoea—Orlistat—type 2 diabetes mellitus	2.51e-05	0.000398	CcSEcCtD
Captopril—Feeling abnormal—Losartan—type 2 diabetes mellitus	2.47e-05	0.000392	CcSEcCtD
Captopril—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	2.45e-05	0.000389	CcSEcCtD
Captopril—Dizziness—Valsartan—type 2 diabetes mellitus	2.45e-05	0.000389	CcSEcCtD
Captopril—Anorexia—Ramipril—type 2 diabetes mellitus	2.45e-05	0.000389	CcSEcCtD
Captopril—Dizziness—Orlistat—type 2 diabetes mellitus	2.42e-05	0.000384	CcSEcCtD
Captopril—Asthenia—Metformin—type 2 diabetes mellitus	2.42e-05	0.000384	CcSEcCtD
Captopril—Hypotension—Ramipril—type 2 diabetes mellitus	2.4e-05	0.000381	CcSEcCtD
Captopril—Nausea—Gliclazide—type 2 diabetes mellitus	2.4e-05	0.00038	CcSEcCtD
Captopril—Pruritus—Metformin—type 2 diabetes mellitus	2.39e-05	0.000379	CcSEcCtD
Captopril—Abdominal pain—Losartan—type 2 diabetes mellitus	2.37e-05	0.000376	CcSEcCtD
Captopril—Body temperature increased—Losartan—type 2 diabetes mellitus	2.37e-05	0.000376	CcSEcCtD
Captopril—Vomiting—Valsartan—type 2 diabetes mellitus	2.36e-05	0.000374	CcSEcCtD
Captopril—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	2.34e-05	0.000372	CcSEcCtD
Captopril—Rash—Valsartan—type 2 diabetes mellitus	2.34e-05	0.000371	CcSEcCtD
Captopril—Dermatitis—Valsartan—type 2 diabetes mellitus	2.34e-05	0.00037	CcSEcCtD
Captopril—Vomiting—Orlistat—type 2 diabetes mellitus	2.33e-05	0.000369	CcSEcCtD
Captopril—Insomnia—Ramipril—type 2 diabetes mellitus	2.33e-05	0.000369	CcSEcCtD
Captopril—Headache—Valsartan—type 2 diabetes mellitus	2.32e-05	0.000368	CcSEcCtD
Captopril—ABCB1—liver—type 2 diabetes mellitus	2.32e-05	0.000582	CbGeAlD
Captopril—Diarrhoea—Metformin—type 2 diabetes mellitus	2.31e-05	0.000366	CcSEcCtD
Captopril—Rash—Orlistat—type 2 diabetes mellitus	2.31e-05	0.000366	CcSEcCtD
Captopril—Paraesthesia—Ramipril—type 2 diabetes mellitus	2.31e-05	0.000366	CcSEcCtD
Captopril—Dermatitis—Orlistat—type 2 diabetes mellitus	2.31e-05	0.000366	CcSEcCtD
Captopril—Headache—Orlistat—type 2 diabetes mellitus	2.29e-05	0.000364	CcSEcCtD
Captopril—Dyspnoea—Ramipril—type 2 diabetes mellitus	2.29e-05	0.000364	CcSEcCtD
Captopril—Asthenia—Irbesartan—type 2 diabetes mellitus	2.29e-05	0.000363	CcSEcCtD
Captopril—Somnolence—Ramipril—type 2 diabetes mellitus	2.29e-05	0.000363	CcSEcCtD
Captopril—Dyspepsia—Ramipril—type 2 diabetes mellitus	2.26e-05	0.000359	CcSEcCtD
Captopril—Pruritus—Irbesartan—type 2 diabetes mellitus	2.25e-05	0.000358	CcSEcCtD
Captopril—Decreased appetite—Ramipril—type 2 diabetes mellitus	2.23e-05	0.000355	CcSEcCtD
Captopril—Dizziness—Metformin—type 2 diabetes mellitus	2.23e-05	0.000354	CcSEcCtD
Captopril—Fatigue—Ramipril—type 2 diabetes mellitus	2.22e-05	0.000352	CcSEcCtD
Captopril—Nausea—Valsartan—type 2 diabetes mellitus	2.2e-05	0.000349	CcSEcCtD
Captopril—Constipation—Ramipril—type 2 diabetes mellitus	2.2e-05	0.000349	CcSEcCtD
Captopril—Diarrhoea—Irbesartan—type 2 diabetes mellitus	2.18e-05	0.000346	CcSEcCtD
Captopril—Nausea—Orlistat—type 2 diabetes mellitus	2.18e-05	0.000345	CcSEcCtD
Captopril—Asthenia—Losartan—type 2 diabetes mellitus	2.15e-05	0.000341	CcSEcCtD
Captopril—Vomiting—Metformin—type 2 diabetes mellitus	2.15e-05	0.000341	CcSEcCtD
Captopril—Rash—Metformin—type 2 diabetes mellitus	2.13e-05	0.000338	CcSEcCtD
Captopril—Dermatitis—Metformin—type 2 diabetes mellitus	2.13e-05	0.000337	CcSEcCtD
Captopril—Pruritus—Losartan—type 2 diabetes mellitus	2.12e-05	0.000337	CcSEcCtD
Captopril—Feeling abnormal—Ramipril—type 2 diabetes mellitus	2.12e-05	0.000336	CcSEcCtD
Captopril—Headache—Metformin—type 2 diabetes mellitus	2.11e-05	0.000336	CcSEcCtD
Captopril—Dizziness—Irbesartan—type 2 diabetes mellitus	2.11e-05	0.000334	CcSEcCtD
Captopril—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	2.1e-05	0.000333	CcSEcCtD
Captopril—Diarrhoea—Losartan—type 2 diabetes mellitus	2.05e-05	0.000325	CcSEcCtD
Captopril—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.03e-05	0.000322	CcSEcCtD
Captopril—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.03e-05	0.000322	CcSEcCtD
Captopril—Vomiting—Irbesartan—type 2 diabetes mellitus	2.03e-05	0.000321	CcSEcCtD
Captopril—Rash—Irbesartan—type 2 diabetes mellitus	2.01e-05	0.000319	CcSEcCtD
Captopril—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.01e-05	0.000318	CcSEcCtD
Captopril—Nausea—Metformin—type 2 diabetes mellitus	2.01e-05	0.000318	CcSEcCtD
Captopril—Headache—Irbesartan—type 2 diabetes mellitus	2e-05	0.000317	CcSEcCtD
Captopril—Dizziness—Losartan—type 2 diabetes mellitus	1.98e-05	0.000315	CcSEcCtD
Captopril—Vomiting—Losartan—type 2 diabetes mellitus	1.91e-05	0.000302	CcSEcCtD
Captopril—Nausea—Irbesartan—type 2 diabetes mellitus	1.89e-05	0.0003	CcSEcCtD
Captopril—Rash—Losartan—type 2 diabetes mellitus	1.89e-05	0.0003	CcSEcCtD
Captopril—Dermatitis—Losartan—type 2 diabetes mellitus	1.89e-05	0.0003	CcSEcCtD
Captopril—Headache—Losartan—type 2 diabetes mellitus	1.88e-05	0.000298	CcSEcCtD
Captopril—Asthenia—Ramipril—type 2 diabetes mellitus	1.84e-05	0.000293	CcSEcCtD
Captopril—Pruritus—Ramipril—type 2 diabetes mellitus	1.82e-05	0.000289	CcSEcCtD
Captopril—Nausea—Losartan—type 2 diabetes mellitus	1.78e-05	0.000283	CcSEcCtD
Captopril—Diarrhoea—Ramipril—type 2 diabetes mellitus	1.76e-05	0.000279	CcSEcCtD
Captopril—Dizziness—Ramipril—type 2 diabetes mellitus	1.7e-05	0.00027	CcSEcCtD
Captopril—Vomiting—Ramipril—type 2 diabetes mellitus	1.63e-05	0.000259	CcSEcCtD
Captopril—Rash—Ramipril—type 2 diabetes mellitus	1.62e-05	0.000257	CcSEcCtD
Captopril—Dermatitis—Ramipril—type 2 diabetes mellitus	1.62e-05	0.000257	CcSEcCtD
Captopril—Headache—Ramipril—type 2 diabetes mellitus	1.61e-05	0.000255	CcSEcCtD
Captopril—Nausea—Ramipril—type 2 diabetes mellitus	1.53e-05	0.000242	CcSEcCtD
Captopril—F2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.98e-06	4.08e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—LPA—type 2 diabetes mellitus	1.98e-06	4.08e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	1.98e-06	4.08e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GCKR—type 2 diabetes mellitus	1.98e-06	4.08e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	1.98e-06	4.08e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.97e-06	4.06e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.96e-06	4.04e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	1.96e-06	4.04e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.96e-06	4.03e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	1.95e-06	4.03e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.94e-06	4.01e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	1.92e-06	3.96e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	1.92e-06	3.96e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	1.92e-06	3.96e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	1.92e-06	3.95e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	1.91e-06	3.93e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.9e-06	3.92e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	1.9e-06	3.91e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.9e-06	3.91e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.88e-06	3.87e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	1.88e-06	3.87e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—INS—type 2 diabetes mellitus	1.87e-06	3.86e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	1.87e-06	3.85e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.86e-06	3.84e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	1.85e-06	3.81e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.84e-06	3.8e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.84e-06	3.8e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	1.84e-06	3.79e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—C3—type 2 diabetes mellitus	1.82e-06	3.75e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.81e-06	3.74e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.81e-06	3.73e-05	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.81e-06	3.73e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	1.81e-06	3.72e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.81e-06	3.72e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	1.79e-06	3.7e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.78e-06	3.68e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	1.76e-06	3.63e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.76e-06	3.62e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	1.75e-06	3.61e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.74e-06	3.58e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	1.73e-06	3.57e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.73e-06	3.57e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.73e-06	3.57e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	1.73e-06	3.57e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.73e-06	3.57e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AGT—type 2 diabetes mellitus	1.73e-06	3.56e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.72e-06	3.55e-05	CbGpPWpGaD
Captopril—F2—Hemostasis—AKT1—type 2 diabetes mellitus	1.72e-06	3.55e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.7e-06	3.5e-05	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.7e-06	3.5e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—LEP—type 2 diabetes mellitus	1.69e-06	3.49e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—APOE—type 2 diabetes mellitus	1.69e-06	3.49e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	1.69e-06	3.49e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.67e-06	3.45e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	1.66e-06	3.43e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	1.65e-06	3.39e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.64e-06	3.39e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.64e-06	3.39e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	1.64e-06	3.38e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	1.64e-06	3.37e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	1.63e-06	3.37e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	1.63e-06	3.37e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	1.63e-06	3.37e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	1.63e-06	3.37e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	1.61e-06	3.32e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—MTR—type 2 diabetes mellitus	1.61e-06	3.32e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.6e-06	3.29e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.58e-06	3.27e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	1.58e-06	3.26e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.57e-06	3.24e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GCK—type 2 diabetes mellitus	1.57e-06	3.24e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—HBA1—type 2 diabetes mellitus	1.57e-06	3.24e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—LIPC—type 2 diabetes mellitus	1.57e-06	3.24e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	1.57e-06	3.23e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	1.56e-06	3.22e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	1.56e-06	3.21e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RELA—type 2 diabetes mellitus	1.55e-06	3.19e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	1.55e-06	3.18e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	1.53e-06	3.16e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CETP—type 2 diabetes mellitus	1.52e-06	3.13e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.51e-06	3.11e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.49e-06	3.06e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	1.49e-06	3.06e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	1.49e-06	3.06e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	1.46e-06	3e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—INS—type 2 diabetes mellitus	1.45e-06	2.98e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.44e-06	2.97e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.42e-06	2.93e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	1.41e-06	2.91e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	1.41e-06	2.91e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	1.41e-06	2.91e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	1.41e-06	2.91e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	1.41e-06	2.91e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.4e-06	2.89e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.4e-06	2.88e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.4e-06	2.88e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.39e-06	2.87e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	1.39e-06	2.86e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CTGF—type 2 diabetes mellitus	1.38e-06	2.85e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	1.38e-06	2.84e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	1.38e-06	2.84e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	1.38e-06	2.84e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	1.37e-06	2.83e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.37e-06	2.82e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	1.36e-06	2.8e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.35e-06	2.79e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.34e-06	2.77e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	1.34e-06	2.77e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	1.33e-06	2.74e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	1.33e-06	2.74e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.33e-06	2.74e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	1.33e-06	2.74e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	1.32e-06	2.73e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	1.31e-06	2.69e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.3e-06	2.69e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.3e-06	2.69e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	1.3e-06	2.67e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	1.3e-06	2.67e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	1.3e-06	2.67e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	1.29e-06	2.66e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	1.29e-06	2.66e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	1.27e-06	2.63e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	1.27e-06	2.63e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.27e-06	2.62e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.27e-06	2.62e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	1.27e-06	2.61e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	1.25e-06	2.58e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	1.24e-06	2.56e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.24e-06	2.55e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	1.24e-06	2.55e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	1.24e-06	2.55e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	1.24e-06	2.55e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GCG—type 2 diabetes mellitus	1.22e-06	2.52e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	1.22e-06	2.52e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SRC—type 2 diabetes mellitus	1.22e-06	2.51e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	1.21e-06	2.5e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	1.2e-06	2.48e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.19e-06	2.46e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.18e-06	2.44e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.18e-06	2.43e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.18e-06	2.42e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	1.16e-06	2.4e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	1.16e-06	2.4e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	1.16e-06	2.4e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	1.14e-06	2.35e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	1.13e-06	2.33e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.13e-06	2.33e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.12e-06	2.3e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.12e-06	2.3e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	1.11e-06	2.28e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—SRC—type 2 diabetes mellitus	1.1e-06	2.26e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.09e-06	2.24e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.09e-06	2.24e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.09e-06	2.24e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.08e-06	2.22e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	1.07e-06	2.21e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.07e-06	2.21e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.07e-06	2.21e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	1.07e-06	2.21e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.07e-06	2.2e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	1.06e-06	2.19e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.05e-06	2.17e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GNB3—type 2 diabetes mellitus	1.05e-06	2.17e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.05e-06	2.17e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.05e-06	2.17e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	1.05e-06	2.16e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CAT—type 2 diabetes mellitus	1.03e-06	2.13e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	1.03e-06	2.12e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.02e-06	2.1e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	1.01e-06	2.08e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	1.01e-06	2.08e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.01e-06	2.08e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—APOB—type 2 diabetes mellitus	1e-06	2.07e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.88e-07	2.04e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	9.82e-07	2.02e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	9.77e-07	2.01e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—LPL—type 2 diabetes mellitus	9.59e-07	1.98e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	9.39e-07	1.94e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SRC—type 2 diabetes mellitus	9.39e-07	1.93e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GPX1—type 2 diabetes mellitus	9.36e-07	1.93e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	9.23e-07	1.9e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.23e-07	1.9e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	9.19e-07	1.89e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.14e-07	1.88e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CD36—type 2 diabetes mellitus	9.11e-07	1.88e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	9.07e-07	1.87e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	9e-07	1.85e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	8.8e-07	1.81e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.7e-07	1.79e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	8.7e-07	1.79e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	8.66e-07	1.78e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	8.64e-07	1.78e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	8.56e-07	1.76e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	8.54e-07	1.76e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PPARA—type 2 diabetes mellitus	8.47e-07	1.75e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	8.4e-07	1.73e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.39e-07	1.73e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	8.29e-07	1.71e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.23e-07	1.7e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	8.23e-07	1.7e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—AGT—type 2 diabetes mellitus	8.2e-07	1.69e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	8.2e-07	1.69e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL6—type 2 diabetes mellitus	8.19e-07	1.69e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CALM1—type 2 diabetes mellitus	8.07e-07	1.66e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	8.07e-07	1.66e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—APOE—type 2 diabetes mellitus	8.04e-07	1.66e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	7.98e-07	1.65e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—APOA1—type 2 diabetes mellitus	7.95e-07	1.64e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	7.92e-07	1.63e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	7.88e-07	1.62e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	7.75e-07	1.6e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	7.73e-07	1.59e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	7.57e-07	1.56e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.56e-07	1.56e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	7.52e-07	1.55e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	7.43e-07	1.53e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	7.42e-07	1.53e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	7.19e-07	1.48e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	7.13e-07	1.47e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	7.07e-07	1.46e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	7.04e-07	1.45e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PPARG—type 2 diabetes mellitus	7e-07	1.44e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	6.99e-07	1.44e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	6.96e-07	1.44e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—INS—type 2 diabetes mellitus	6.87e-07	1.42e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	6.83e-07	1.41e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	6.77e-07	1.4e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	6.66e-07	1.37e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	6.64e-07	1.37e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	6.56e-07	1.35e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL6—type 2 diabetes mellitus	6.32e-07	1.3e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	6.14e-07	1.26e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	6.02e-07	1.24e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—NOS3—type 2 diabetes mellitus	6.02e-07	1.24e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—INS—type 2 diabetes mellitus	6.02e-07	1.24e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.83e-07	1.2e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	5.78e-07	1.19e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	5.67e-07	1.17e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	5.52e-07	1.14e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	5.51e-07	1.14e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.28e-07	1.09e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	5.28e-07	1.09e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	5.2e-07	1.07e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	4.97e-07	1.02e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	4.97e-07	1.02e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	4.83e-07	9.95e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	4.55e-07	9.37e-06	CbGpPWpGaD
Captopril—ALB—Metabolism—AKT1—type 2 diabetes mellitus	2.77e-07	5.71e-06	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	2.43e-07	5e-06	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	2.29e-07	4.71e-06	CbGpPWpGaD
